My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 347

    1.

    A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss.

    Ropelle ER, Pauli JR, Fernandes MF, Rocco SA, Marin RM, Morari J, Souza KK, Dias MM, Gomes-Marcondes MC, Gontijo JA, Franchini KG, Velloso LA, Saad MJ, Carvalheira JB.

    Diabetes. 2008 Mar;57(3):594-605. Epub 2007 Dec 5.PMID: 18057094 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.

    Du M, Shen QW, Zhu MJ, Ford SP.

    J Anim Sci. 2007 Apr;85(4):919-27. Epub 2006 Dec 18.PMID: 17178807 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.

    Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV.

    J Biol Chem. 2004 May 7;279(19):19970-6. Epub 2004 Mar 17.PMID: 15028725 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver.

    Jiang W, Zhu Z, Thompson HJ.

    Cancer Res. 2008 Jul 1;68(13):5492-9.PMID: 18593953 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.

    Deshmukh AS, Treebak JT, Long YC, Viollet B, Wojtaszewski JF, Zierath JR.

    Mol Endocrinol. 2008 May;22(5):1105-12. Epub 2008 Feb 14.PMID: 18276828 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    AMP-activated protein kinase plays a role in the control of food intake.

    Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ.

    J Biol Chem. 2004 Mar 26;279(13):12005-8. Epub 2004 Jan 23.PMID: 14742438 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase.

    Jang EH, Moon JS, Ko JH, Ahn CW, Lee HH, Shin JK, Park CS, Kang JH.

    Int J Obes (Lond). 2008 Jul;32(7):1161-70. Epub 2008 Apr 15.PMID: 18414417 [PubMed - indexed for MEDLINE]Related articles

    8.

    Central exercise action increases the AMPK and mTOR response to leptin.

    Ropelle ER, Fernandes MF, Flores MB, Ueno M, Rocco S, Marin R, Cintra DE, Velloso LA, Franchini KG, Saad MJ, Carvalheira JB.

    PLoS One. 2008;3(12):e3856. Epub 2008 Dec 4.PMID: 19052642 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hypothalamic mTOR signaling regulates food intake.

    Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ.

    Science. 2006 May 12;312(5775):927-30.PMID: 16690869 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.

    Jiang W, Zhu Z, Thompson HJ.

    Mol Carcinog. 2008 Aug;47(8):616-28.PMID: 18247380 [PubMed - indexed for MEDLINE]Related articles

    11.

    Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice.

    Mooney MH, Fogarty S, Stevenson C, Gallagher AM, Palit P, Hawley SA, Hardie DG, Coxon GD, Waigh RD, Tate RJ, Harvey AL, Furman BL.

    Br J Pharmacol. 2008 Apr;153(8):1669-77. Epub 2008 Feb 25.PMID: 18297106 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    mTOR integrates amino acid- and energy-sensing pathways.

    Tokunaga C, Yoshino K, Yonezawa K.

    Biochem Biophys Res Commun. 2004 Jan 9;313(2):443-6. Review.PMID: 14684182 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nutrient signalling in the regulation of human muscle protein synthesis.

    Fujita S, Dreyer HC, Drummond MJ, Glynn EL, Cadenas JG, Yoshizawa F, Volpi E, Rasmussen BB.

    J Physiol. 2007 Jul 15;582(Pt 2):813-23. Epub 2007 May 3.PMID: 17478528 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.

    Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N.

    J Biol Chem. 2005 Sep 16;280(37):32081-9. Epub 2005 Jul 15.PMID: 16027121 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.

    Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB.

    Diabetes. 2006 Aug;55(8):2256-64.PMID: 16873688 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.

    Thomson DM, Fick CA, Gordon SE.

    J Appl Physiol. 2008 Mar;104(3):625-32. Epub 2008 Jan 10.PMID: 18187610 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status.

    Cheng SW, Fryer LG, Carling D, Shepherd PR.

    J Biol Chem. 2004 Apr 16;279(16):15719-22. Epub 2004 Feb 17.PMID: 14970221 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice.

    Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA, Kemp BE.

    Endocrinology. 2006 Aug;147(8):3906-14. Epub 2006 May 4.PMID: 16675525 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats.

    Namkoong C, Kim MS, Jang PG, Han SM, Park HS, Koh EH, Lee WJ, Kim JY, Park IS, Park JY, Lee KU.

    Diabetes. 2005 Jan;54(1):63-8.PMID: 15616011 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection.

    Kudchodkar SB, Del Prete GQ, Maguire TG, Alwine JC.

    J Virol. 2007 Apr;81(7):3649-51. Epub 2007 Jan 10.PMID: 17215282 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity